Affiliation:
1. Department of Health Sciences, College of Natural and Health Sciences, Zayed University, Abu Dhabi 144534, United Arab Emirates
Abstract
Hyperglycemia, which is a chronic metabolic condition caused by either a defect in insulin secretion or insulin resistance, is a hallmark of diabetes mellitus (DM). Sustained hyperglycemia leads to the onset and development of many health complications. Despite the number of available antidiabetic medications on the market, there is still a need for novel treatment agents with increased efficacy and fewer adverse effects. Many medicinal plants offer a rich supply of bioactive compounds that have remarkable pharmacological effects with less toxicity and side effects. According to published evidence, natural antidiabetic substances influence pancreatic β-cell development and proliferation, inhibit pancreatic β-cell death, and directly increase insulin output. Pancreatic ATP-sensitive potassium channels play an essential role in coupling glucose metabolism to the secretion of insulin. Although much of the literature is available on the antidiabetic effects of medicinal plants, very limited studies discuss their direct action on pancreatic KATP. The aim of this review is to focus on the modulatory effects of antidiabetic medicinal plants and their active constituents on pancreatic KATP. The KATP channel should be regarded as a key therapeutic milestone in the treatment of diabetes. Therefore, continuous research into the interaction of medicinal plants with the KATP channel is crucial.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference114 articles.
1. Advanced glycation end products in diabetes, cancer and phytochemical therapy;Dariya;Drug Discov. Today,2020
2. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030;Wild;Diabetes Care,2004
3. Antidiabetic potential of medicinal plants;Malviya;Acta Pol. Pharm.,2010
4. Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae);Kamgang;J. Nat. Med.,2008
5. Al Kury, L.T., Abdoh, A., Ikbariah, K., Sadek, B., and Mahgoub, M. (2022). In vitro and in vivo antidiabetic potential of monoterpenoids: An update. Molecules, 27.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献